Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Scandinavian Journal of Gastroenterology|October 1, 1998
Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgroupingJ M Hansen, P Bytzer, O B Schaffalitzky De Muckadell
Alimentary Pharmacology & Therapeutics|January 3, 2001
Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitusP Bytzer, N J Talley, M P Jones, et al.
Ugeskrift for Laeger|June 9, 1997
[NSAID and ulcer complications. An analysis of risk factors]J M Hansen, J Hallas, J M Lauritsen, et al.
Ugeskrift for Laeger|February 13, 1995
[Survey of patients with upper gastrointestinal tract dyspepsia. A trial of H2 blocker therapy or endoscopy--a randomized trial of 2 management methods]P Bytzer, J M Hansen, O B Schaffalitzky de Muckadell
Alimentary Pharmacology & Therapeutics|August 7, 2012
Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patientsP Bytzer, S Veldhuyzen van Zanten, H Mattsson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 30, 2006
Irritable bowel syndrome: the burden and unmet needs in EuropeE M M Quigley, P Bytzer, R Jones, et al.
Ugeskrift for Laeger|May 13, 1991
[Over-the-counter availability of potent ulcer drugs. Study of changes in the drug use pattern and the pressure on diagnostic measures]P Bytzer, J M Hansen, O B Schaffalitzky de Muckadell
Ugeskrift for Laeger|August 27, 1990
[The use of services of the physician-on-call by chronic morphine users]V M Schmidt
Scandinavian Journal of Gastroenterology|January 1, 1985
Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer. A double-blind controlled trialK Lauritsen, P Bytzer, J Hansen, et al.
Alimentary Pharmacology & Therapeutics|May 3, 2017
Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptomsC Coyle, G Crawford, J Wilkinson, et al.
Pageof 9